LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of LianMedical - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. LianMedical - ADR market cap is $7.64M.
What is the 52-week high for LianMedical - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. LianMedical - ADR 52 week high is $0.1768 as of July 23, 2026.
What is the 52-week low for LianMedical - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. LianMedical - ADR 52 week low is $0.048 as of July 23, 2026.
What is LianMedical - ADR stock price today?
LianMedical - ADR stock price today is $0.0718.
What was LianMedical - ADR stock price yesterday?
LianMedical - ADR stock price yesterday was $0.07.
What is the 50-day moving average of LianMedical - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. LianMedical - ADR 50-day moving average is $0.1187.